Chronic kidney disease has more than doubled since 1990, now affecting nearly 800 million people worldwide
Peer-Reviewed Publication
Updates every hour. Last Updated: 23-Dec-2025 00:11 ET (23-Dec-2025 05:11 GMT/UTC)
A recent analysis of 2,915 patients with primary glomerular diseases indicatesthat young patients may face similar risks of kidney function decline as older patients, indicating that they are more likely to need dialysis or a kidney transplant during their lifetimes.
The findings will be presented at American Society of Nephrology (ASN)Kidney Week 2025 November 5–9.
Dual inhibition of sodium-glucose co-transporters 1 and 2 with the recently approved drug sotagliflozin may be an especially effectivetreatment for salt- sensitive hypertension.
The findings will be presented at American Society of Nephrology (ASN)Kidney Week 2025 November 5–9.
Nearly all SPRINT participants with hypertension and nondiabetic chronickidney disease stages 3–4 had a net benefit (the predicted difference between benefits and harms) that favored a systolic blood pressure target of <120 mm Hg compared with <140 mm Hg.
The findings will be presented at American Society of Nephrology (ASNKidney Week 2025 November 5–9.